Used in research for cancer treatment, particularly glioblastoma, due to its ability to inhibit integrins involved in tumor angiogenesis and cell survival. It blocks the binding of extracellular matrix proteins to integrin receptors, disrupting blood vessel formation and tumor growth. Though clinical trials showed limited efficacy in late-stage cancers, it remains a tool compound for studying integrin signaling pathways in oncology.